In addition, the expression of glucose transporters GLUT1 and GLUT2 is increased in HCC, and while GLUT2 overexpression worsens the prognosis of patients, the inhibition of GLUT1 expression attenuates the malignant behavior of HCC cells [36,37,38]. The gene discussed is SLC2A2; the disease is hepatocellular carcinoma.